OBD Insider Trading

Insider Ownership Percentage: 30.52%
Insider Buying (Last 12 Months): £21,550.95
Insider Selling (Last 12 Months): £389,510

Oxford BioDynamics Insider Trading History Chart

This chart shows the insider buying and selling history at Oxford BioDynamics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Oxford BioDynamics Share Price & Price History

Current Price: GBX 27
Price Change: Price Increase of +0.004 (0.01%)
As of 12/11/2023 08:31 AM ET

This chart shows the closing price history over time for OBD up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Oxford BioDynamics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/10/2023Stephen Charles DiggleInsiderSell125,000GBX 34£42,500
10/18/2023Stephen Charles DiggleInsiderSell777,000GBX 38£295,260
10/4/2023Stephen Charles DiggleInsiderSell115,000GBX 45£51,750
1/26/2023Stephen Charles DiggleInsiderBuy143,673GBX 15£21,550.95
11/11/2022Stephen Charles DiggleInsiderBuy50,000GBX 18£9,000
5/20/2022Matthew WakefieldInsiderBuy25,000GBX 17£4,250
4/6/2022Paul StockdaleInsiderBuy30,000GBX 18£5,400
3/2/2022Stephen Charles DiggleInsiderBuy400,000GBX 22£88,000
2/7/2022Jon BurrowsInsiderBuy50,000GBX 30£15,000
1/25/2022Alexandre AkoulitchevInsiderBuy100,000GBX 30£30,000
12/24/2021Matthew WakefieldInsiderBuy31,187GBX 33£10,291.71
12/1/2021Paul StockdaleInsiderBuy12,000GBX 42£5,040
11/19/2021Stephen Charles DiggleInsiderBuy99,471GBX 42£41,777.82
6/15/2021Paul StockdaleInsiderBuy8,000GBX 56£4,480
See Full Table

SEC Filings (Institutional Ownership Changes) for Oxford BioDynamics (LON:OBD)

50.87% of Oxford BioDynamics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Oxford BioDynamics logo
Oxford BioDynamics Plc, a biotechnology company, discovers and develops biomarkers for use in the pharmaceutical and biotechnology industry primarily in the United States and the United Kingdom. The company provides EpiSwitch, a proprietary technology platform that enables screening, evaluation, validation, and monitoring of 3D genomic biomarkers to diagnose patients. Its products include EpiSwitch CiRT (Checkpoint Inhibitor Response Test), a blood test for predicting therapeutic response to checkpoint inhibitor immunotherapy; EpiSwitch CST (Covid Severity Test), an advanced blood test for the prediction of COVID-19 severity in adults; and EpiSwitch Explorer Array Kit for high-resolution 3D genome profiling. Oxford BioDynamics Plc was incorporated in 2007 and is headquartered in Oxford, the United Kingdom.
Read More on Oxford BioDynamics

Today's Range

Now: GBX 27
Low: 26.10
High: 27.72

50 Day Range

MA: GBX 33.06
Low: 26
High: 47

52 Week Range

Now: GBX 27
Low: 9.20
High: 52


391,611 shs

Average Volume

774,738 shs

Market Capitalization

£54.63 million

P/E Ratio


Dividend Yield




Who are the company insiders with the largest holdings of Oxford BioDynamics?

Oxford BioDynamics' top insider shareholders include:
  1. Alexandre Akoulitchev (Insider)
  2. Jon Burrows (Insider)
  3. Matthew Wakefield (Insider)
  4. Paul Stockdale (Insider)
  5. Stephen Charles Diggle (Insider)
Learn More about top insider investors at Oxford BioDynamics.